UCLA HF Guideline
Angiotensin Receptor Antagonists: Hemodynamic and symptomatic benefits demonstrated. ELITE II showed a low dose of the ARB losartan was not superior or equivalent to ACE inhibitor treatment. CHARM demonstrated benefits of ARB in ACE intolerant patients as well as in patients on ACE inhibitors. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.